The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Playtech Sinks On Asia Profit Warning

Mon, 02nd Jul 2018 10:58

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------Micro Focus International, up 5.5%. The software firm said Monday it has agreed to sell its SUSE business segment to Blitz 18-679, a subsidiary of Swedish private equity group EQT Partners for USD2.54 billion. The SUSE business develops, markets and sources an enterprise grade Linux operating systems well as open source software-defined infrastructure. Proceeds from the sale will go towards paying any tax coming from the transaction, repaying part of the group's debt, general corporate purposes and shareholder returns. The disposal is expected to be completed in the first quarter of 2019.Tesco, up 0.4%. The supermarket chain said it intends to form a three-year strategic alliance with French retail giant Carrefour. Tesco is set to form a partnership with Carrefour covering relationship with global suppliers, joint purchasing of own brand products and goods not for resale, Tesco said. The alliance will allow both companies to lower their prices and enhance competitiveness, the supermarket said. The deal is expected to be formally agreed within the next two months. ----------FTSE 100 - LOSERS----------Antofagasta, down 3.1%, Anglo American, down 2.9%, BHP Billiton, down 2.7%, Rio Tinto, down 2.7%. The miners were lower following disappointing manufacturing PMI data from China. The manufacturing sector in China continued to expand in June, albeit at a slower rate, the latest survey from Caixin revealed on Monday with a manufacturing PMI score of 51.0. The score is down from 51.1 in May, although it remains above the boom-or-bust line of 50 that separates expansion of contraction. ----------FTSE 250 - WINNERS----------Vedanta Resources, up 27% at 822.00 pence. Shares in the Indian miner surged after majority shareholder and Chairman Anil Agarwal made an offer to acquire the remaining stake for GBP778 million. The offer priced at 825 pence per share values Vedanta at GBP2.33 billion and represents a premium of 27.6% to the closing share price of 647.0p on Friday and 13.5% to Vedanta's three-month volume weighted average price of 727 pence. Under the agreement, Vedanta shareholders will also receive previously announced dividend of USD0.41 per share. Including the dividend payment, the total offer is valued at 856p per Vedanta share. Volcan Investments intends to cancel Vedanta share trading on the London Stock Exchange's main market following completion of the deal. Under UK takeover rules, Volcan is required to make a firm offer for Vedanta by July 30.Meggitt, up 4.2%. The aerospace and defence components engineer upped its full-year earnings guidance after "stronger than anticipated trading" in the second quarter. The company said it now expects total organic revenue for 2018 to increase between 4% and 6%. Previously the company's forecast saw revenue up by between 2% to 4%. By division, Meggitt expects revenue growth of 4% to 6% in Civil Aftermarket, up from previous guidance of 3% to 5%, due to a combination of "strong growth" in air traffic and low levels of aircraft retirements. However, the group said it expects margins to be towards the lower end of the guidance range set between 17.7% to 18.0%, due to a "slower than anticipated" recovery at Meggitt Polymers & Composites.----------FTSE 250 - LOSERS----------Playtech, down 27%. The gaming and financial technology provider said it expects revenue from its Asian operation lower than forecast. The company expects its full-year 2018 adjusted earnings to be higher than in 2017, despite suffering a "disappointing" performance in Asia. Playtech said it forecast adjusted earnings before interest, taxes, depreciation and amortisation to be in the range of EUR320 million to EUR360 million. For 2017, Playtech reported adjusted Ebitda of EUR322.1 million. In Asia, due to an "increasingly competitive backdrop" Playtech expects revenue to be EUR70 million lower than it originally forecast. ----------OTHER MAIN MARKET AND AIM - WINNERS----------Carclo, up 17% at 94.84p. Drug and medical device company Consort Medical said the plastics supplier rejected its non-binding acquisition proposal. Consort Medical's offer valued each of Carclo share at 116 pence, with the total consideration to be fulfilled issuing new Consort shares. As of June 29, the valuation implied an exchange ratio of 0.0973 Consort shares for each Carclo share. The proposal was at a premium of 43.6% to the Carclo closing share price of 80.8 pence June 29. Consort believes the proposal would offer a "number of attractive benefits" to Carclo shareholder. However it said there is "no certainty" it will make a further offer. Consort Medical was up 4.0%. ----------OTHER MAIN MARKET AND AIM - LOSERS----------eve Sleep, down 58%. The online mattress retailer said its Chief Executive Officer Jas Bagniewski departed amid sales falling short of expectations for the first half of its financial year. For the six months to the end of June, group sales were up by 61% to GBP18.6 million. This revenue shortfall is not expected to be recovered in the usually stronger second half due to a pull back from non-core markets. As a result, UK profitability will be delayed from the fourth quarter of 2018. eve Sleep said that for the six-month period trading patterns experienced greater volatility due to a challenging backdrop for consumer spending, as well as "strategic missteps" on management's part. With "mutual consent" Bagniewski has stepped down from his role and the company, after founding the company in 2014. Chief Financial Officer Abid Ismail will take on his executive duties alongside his own.----------
More News
3 Jan 2017 08:10

Consort Medical splutters as BAT stubs out Voke programme

(ShareCast News) - British American Tobacco has terminated an agreement with Consort Medical over the manufacture of nicotine inhalers for its Voke development programme. Consort, which said it was in "constructive dialogue" with BAT's Nicovations arm and product developer Kind Consumer over the fut

Read more
6 Dec 2016 08:18

Consort Medical posts good growth in first half

(ShareCast News) - Single source drug and delivery device company Consort Medical announced its interim results for the six months to 31 October on Tuesday. The London-listed firm said group revenue increased to £144.9m from £135.5m, representing underlying growth of 2.0% and reported growth of 6.9%

Read more
25 Nov 2016 09:07

Consort Medical appoints new CFO

(ShareCast News) - Consort Medical, a global provider of manufacturing solutions for drugs, announced that it has appointed Paul Hayes as group Finance Director of the Vitec Group. Hayes is taking over the position of chief financial officer from Richard Cotton as well joining the board as executive

Read more
27 Oct 2016 07:45

Consort Medical Welcomes Cimzia Autoclicks Launch On NHS

Read more
14 Oct 2016 12:23

Consort Medical's Bespak inks new agreement

(ShareCast News) - Consort medical, a global single source drug and Delivery device company (CDMO), has announced that its Bespak division has entered into an agreement with a biopharmaceutical company. Bespak manufactures drug delivery devices for pharmaceutical partner companies including respirat

Read more
19 Sep 2016 09:07

Consort Notes European Nod For Bespak Technology-Using Product

Read more
7 Sep 2016 08:43

Consort Medical signs agreement with AstraZeneca

(ShareCast News) - Consort medical, a provider of advanced technology for drugs, has signed a new contract with pharmaceutical giant AstraZeneca for the supply of its Bespak respiratory devices. AstraZeneca and Bespak have agreed to enter into a multi-year agreement for the scale-up and supply of Be

Read more
7 Sep 2016 07:03

Consort Medical Sees Little Brexit Impact; Signs Deal With AstraZeneca

Read more
23 Jun 2016 15:19

Director dealings: Derwent London CEO sells just ahead of Brexit vote

(ShareCast News) - Derwent London chief executive John Burns has sold £1.5m of the FTSE 250 real estate investor's shares in the week just before the EU referendum which could seriously lift or undermine the company's shares. In Wednesday's sale, which comes two days before results for Britain's ref

Read more
17 Jun 2016 09:29

Numis places Consort Medical 'under review'

(ShareCast News) - Consort Medical's shares were put 'under review' by Numis after the company reported its full year results. The pharmaceutical device frim on Thursday reported full year earnings before interest and tax rose 47.6% to £37m as revenues gained 49.8% to £276.9m, driven by a strong per

Read more
16 Jun 2016 14:52

Consort Medical's annual revenues rise as a product launch is delayed

(ShareCast News) - Consort Medical, a pharmaceutical device company, revealed higher full year profits on Thursday due to organic growth and an acquisition. Revenues rose 49.8% to £276.9m from £184.8m the previous financial year. Bespak, the company's drug device manufacturing subsidiary, continued

Read more
16 Jun 2016 07:37

Consort Medical Profit Doubles As Progress Made On DEV610 Programme

Read more
9 Jun 2016 15:04

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
5 Apr 2016 08:32

BROKER RATINGS SUMMARY: Liberum Upgrades Babcock To Hold From Sell

Read more
22 Feb 2016 16:51

Consort Medical agrees partnership and invests in Precision Ocular

(ShareCast News) - Consort Medical has made a £3.3m equity investment for a 13.7% stake in retinal therapeutics specialist Precision Ocular and agreed a development and manufacturing partnership. London-based Precision Ocular has developed retinal treatments that are designed to access specific sma

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.